|
Biolase Inc
BIOL's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Biolase Inc 's sales fell
by -3.39 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1867
Medical Equipment & Supplies industry recorded
growth of revenues by 1.71 %
Biolase Inc net loss decreased from $-5 millions, to $-1 millions in III. Quarter 2024,
• More on BIOL's Growth
|
|
Biolase Inc realized a net loss in trailing twelve months.
Biolase Inc realized cash reduction of $ -0.12 per share in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.01.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.7.
• More on BIOL's Valuation
|
|
|
|
|
Biolase Inc realized net loss in trailing twelve months.
Biolase Inc realized cash outflow of $ -0.12per share in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.01.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.7.
• More on BIOL's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com